MedTrace Logo

Urinary Incontinence and Anxiety in Pregnancy

NCT04942951 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-06-29

No results posted yet for this study

Summary

This prospective case-control study aimed to evaluate the impact of presence, and severity of urinary incontinence (UI) on pregnancy related anxiety. The study included 160 pregnant women with uncomplicated pregnancies at the second trimester. The pregnant women with UI (n=80) were compared to the control group including continent pregnant women (n=80) in terms of Pregnancy-Related Anxiety Scores (PRAQ-R2) and Incontinence Consultation Questionnaire-Short Form (ICIQ-SF) in pregnant women. Pelvic Organ Prolapse Questionnaire (POP-Q) was considered for the diagnosis of pelvic organ prolapsus. The UI was also divided into subgroups as stress (SUI), urge (UUI), and mixed (MUI) types and they were also compared to the control group.

Conditions

Interventions

DIAGNOSTIC_TEST

Gynecological examination

Gynecological examination was performed to the whole pregnant cohort included in the study to diagnose either the pelvic organ prolapse according to the POP-Q system or to be sure that they have no findings of pelvic organ prolapse.

OTHER

Pelvic Organ Prolapse Quantification (POP-Q)

Gynecological examination was performed to the whole pregnant cohort included in the study to diagnose either the pelvic organ prolapse according to the POP-Q system or to be sure that they have no findings of pelvic organ prolapse.

OTHER

Incontinence Consultation Questionnaire-Short Form (ICIQ-SF) questionnaire

ICIQ-SF questionnaire was applied to the Study group to determine the severity of urinary incontinence.

OTHER

Pregnancy-Related Anxiety Questionnaire-Revised 2 (PRAQ-R2) questionnaire

PRAQ-R2 questionnaire was applied to the whole pregnant cohort included in the study to determine their anxiety status.

Sponsors & Collaborators

  • Esin Merve Erol Koç

    lead OTHER

Principal Investigators

  • Esin Merve Erol Koç, MD · Ankara City Hospital Bilkent

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2020-12-30
Completion
2021-06-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942951 on ClinicalTrials.gov